Paper20028821
Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors.
Peatey CL and 8 others. Antimicrob Agents Chemother, 2010. Cited by 28 papers, by iCite.
Cite this record
ConductScience Library. Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors. Papers, record 20028821. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20028821
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antimalarial asexual stage-specific and gametocytocidal activities of HIV protease inhibitors.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antimalarials | Major topic |
| HIV Protease Inhibitors | Major topic |
| Plasmodium falciparum | Major topic |
| Animals | |
| Darunavir | |
| Erythrocytes | |
| Humans | |
| Life Cycle Stages | |
| Parasitic Sensitivity Tests | |
| Pyridines | |
| Pyrones | |
| Sulfonamides |
Source PubMed
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18456554 | HIV and malaria co-infection: interactions and consequences of chemotherapy. | Trends Parasitol | 2008 | https://conductscience.org/library/papers/18456554 | PubMed |
| 2 | 19027798 | A green fluorescent protein-based assay for determining gametocyte production in Plasmodium falciparum. | Mol Biochem Parasitol | 2009 | https://conductscience.org/library/papers/19027798 | PubMed |
| 3 | 17088482 | Synergistic interactions of the antiretroviral protease inhibitors saquinavir and ritonavir with chloroquine and mefloquine against Plasmodium falciparum in vitro. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17088482 | PubMed |
| 4 | 15090809 | HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. | AIDS | 2004 | https://conductscience.org/library/papers/15090809 | PubMed |
| 5 | 16436721 | Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malaria. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16436721 | PubMed |
| 6 | 14522535 | Effect of HIV-1 antiretroviral drugs on cytoadherence and phagocytic clearance of Plasmodium falciparum-parasitised erythrocytes. | Lancet | 2003 | https://conductscience.org/library/papers/14522535 | PubMed |
| 7 | 17437625 | Influence of oxygen on asexual blood cycle and susceptibility of Plasmodium falciparum to chloroquine: requirement of a standardized in vitro assay. | Malar J | 2007 | https://conductscience.org/library/papers/17437625 | PubMed |
| 8 | 16802849 | Tipranavir: a novel nonpeptidic protease inhibitor of HIV. | Clin Pharmacokinet | 2006 | https://conductscience.org/library/papers/16802849 | PubMed |
| 9 | 15980379 | Antimalarial activity of human immunodeficiency virus type 1 protease inhibitors. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/15980379 | PubMed |
| 10 | 17413699 | Antimalarial activity of sera from subjects taking HIV protease inhibitors. | AIDS | 2007 | https://conductscience.org/library/papers/17413699 | PubMed |
| 11 | 18556070 | New treatment options for HIV salvage patients: an overview of second generation PIs, NNRTIs, integrase inhibitors and CCR5 antagonists. | J Infect | 2008 | https://conductscience.org/library/papers/18556070 | PubMed |
| 12 | 16229771 | Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. | Emerg Infect Dis | 2005 | https://conductscience.org/library/papers/16229771 | PubMed |
| 13 | 383936 | Synchronization of Plasmodium falciparum erythrocytic stages in culture. | J Parasitol | 1979 | https://conductscience.org/library/papers/383936 | PubMed |
| 14 | 15331818 | The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. | Am J Trop Med Hyg | 2004 | https://conductscience.org/library/papers/15331818 | PubMed |
| 15 | 19497083 | From malaria control to eradication: The WHO perspective. | Trop Med Int Health | 2009 | https://conductscience.org/library/papers/19497083 | PubMed |
| 16 | 19848586 | Effect of antimalarial drugs on Plasmodium falciparum gametocytes. | J Infect Dis | 2009 | https://conductscience.org/library/papers/19848586 | PubMed |
| 17 | 10997398 | Tipranavir inhibits broadly protease inhibitor-resistant HIV-1 clinical samples. | AIDS | 2000 | https://conductscience.org/library/papers/10997398 | PubMed |
| 18 | 16511422 | Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. | AIDS | 2006 | https://conductscience.org/library/papers/16511422 | PubMed |
| 19 | 15529265 | Antiretrovirals as antimalarial agents. | J Infect Dis | 2004 | https://conductscience.org/library/papers/15529265 | PubMed |
| 20 | 11009139 | Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. | Lancet | 2000 | https://conductscience.org/library/papers/11009139 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36483323 | Malaria an opportunistic infection in HIV/AIDS patients? - A Nigerian experience. | Afr J Lab Med | 2022 | https://conductscience.org/library/papers/36483323 | PubMed |
| 35235480 | Signal peptide peptidase: a potential therapeutic target for parasitic and viral infections. | Expert Opin Ther Targets | 2022 | https://conductscience.org/library/papers/35235480 | PubMed |
| 32731386 | Repurposing Drugs to Fight Hepatic Malaria Parasites. | Molecules | 2020 | https://conductscience.org/library/papers/32731386 | PubMed |
| 32038528 | The Impact of Antiretroviral Therapy on Malaria Parasite Transmission. | Front Microbiol | 2019 | https://conductscience.org/library/papers/32038528 | PubMed |
| 31311649 | HIV protease inhibitors block parasite signal peptide peptidases and prevent growth of Babesia microti parasites in erythrocytes. | Biochem Biophys Res Commun | 2019 | https://conductscience.org/library/papers/31311649 | PubMed |
| 30212437 | Brief Report: Antimalarial Benefit of HIV Antiretroviral Therapy in Areas of Low to Moderate Malaria Transmission Intensity. | J Acquir Immune Defic Syndr | 2018 | https://conductscience.org/library/papers/30212437 | PubMed |
| 29165225 | Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy. | Am J Trop Med Hyg | 2018 | https://conductscience.org/library/papers/29165225 | PubMed |
| 25734014 | Design and Synthesis of Novel Hybrid Molecules against Malaria. | Int J Med Chem | 2015 | https://conductscience.org/library/papers/25734014 | PubMed |
| 25541998 | Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates. | PLoS One | 2014 | https://conductscience.org/library/papers/25541998 | PubMed |
| 25185662 | Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination. | Parasitol Res | 2014 | https://conductscience.org/library/papers/25185662 | PubMed |
| 23907270 | The effect of antiretrovirals on Plasmodium falciparum liver stages. | AIDS | 2013 | https://conductscience.org/library/papers/23907270 | PubMed |
| 23539746 | HIV treatments have malaria gametocyte killing and transmission blocking activity. | J Infect Dis | 2013 | https://conductscience.org/library/papers/23539746 | PubMed |
| 23358639 | Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies. | Am J Trop Med Hyg | 2013 | https://conductscience.org/library/papers/23358639 | PubMed |
| 22509297 | The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatment. | PLoS One | 2012 | https://conductscience.org/library/papers/22509297 | PubMed |
| 22123685 | HIV-1 protease inhibitors and clinical malaria: a secondary analysis of the AIDS Clinical Trials Group A5208 study. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22123685 | PubMed |
| 21876053 | In vitro activity of antiretroviral drugs against Plasmodium falciparum. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21876053 | PubMed |
| 21625331 | Expanding the Antimalarial Drug Arsenal-Now, But How? | Pharmaceuticals (Basel) | 2011 | https://conductscience.org/library/papers/21625331 | PubMed |
| 21486958 | Antimalarial effects of human immunodeficiency virus protease inhibitors in rhesus macaques. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21486958 | PubMed |
| 21266539 | HIV proteinase inhibitors target the Ddi1-like protein of Leishmania parasites. | FASEB J | 2011 | https://conductscience.org/library/papers/21266539 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20028821
GET https://conductscience.org/api/papers/v1/20028821/authors